On behalf of the consortium and the GENOMED4ALL radiomics use case in sickle cell disease, we are presenting an oral abstract regarding the first analysis of the radiomics sickle cell disease part. And first of all, I’d like to say that the GENOMED4ALL is an EU funded project involving 23 centers in Europe. And the fascinating thing is that involves hematologists, neuroradiologists, and artificial intelligence experts and bioinformatics...
On behalf of the consortium and the GENOMED4ALL radiomics use case in sickle cell disease, we are presenting an oral abstract regarding the first analysis of the radiomics sickle cell disease part. And first of all, I’d like to say that the GENOMED4ALL is an EU funded project involving 23 centers in Europe. And the fascinating thing is that involves hematologists, neuroradiologists, and artificial intelligence experts and bioinformatics. So it groups together different expertises.
And the entire title is genomics and personalized medicine for all through artificial intelligence in hematological disorders. So it’s a long title, but what we aim at is joining forces in different specialties to achieve a personalized medicine in multiple myeloma, myelodysplastic syndromes, and sickle cell disease, which is the only benign disease included in the consortium. But we believe we can have some common grounds that can build technologies for the non-malignant and the malignant diseases.